Our Mission: More life for people with cancer
Our work doesn’t stop when the research is done or the discovery is made. The burden of cancer is vast, but so are our aspirations to redefine how this disease is treated.
Latest News
BY THE NUMBERS
544
Talented employees in the U.S. and Germany
61 %
Women working at MorphoSys
43
Nationalities represented across our company
44 %
Leadership positions held by women
Events & Conferences
05
Dec
2023
The JMP Securities Hematology and Oncology Summit (Virtual)
Our CEO, Jean-Paul Kress, M.D., will present the company during a Webcast.
Date: Tuesday, December 5
Time: 12.30pm ET
Access Webcast
11
Dec
2023
ASH 2023 Investor Event with Medical Experts
The event will highlight pelabresib’s potential in first-line myelofibrosis with a comprehensive overview of the Phase 3 MANIFEST-2 trial results, which will be presented during an oral presentation at ASH 2023 on Sunday December 10. There will be live presentations from and a Q&A opportunity with MorphoSys management and leading medical experts.
Monday, December 11, 7:00 a.m. – 8:30 a.m. PST (10:00 a.m. - 11:30 a.m. EST / 4:00 p.m. - 5:30 p.m. CET)
Webcast Presentation
10
Jan
2024
42nd Annual J.P. Morgan Healthcare Conference
Our CEO, Jean-Paul Kress, M.D., will present MorphoSys during a Webcast.
Date: Wednesday, January 10, 2024
Time: 3.00 - 3.40pm PST
Access Webcast